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Glioblastomas (GBMs) are brain tumors characterized by diffuse invasion of cancer cells into the healthy brain parenchyma, and
establishment of secondary foci. GBM cells abundantly express large-conductance, calcium-activated potassium (BK) channels that are
thought to promote cell invasion. Recent evidence suggests that the GBM high invasive potential mainly originates from a pool of stem-like
cells, but the expression and function of BK channels in this cell subpopulation have not been studied.We investigated the expression of BK
channels in GBM stem-like cells using electrophysiological and immunochemical techniques, and assessed their involvement in the
migratory process of this important cell subpopulation. In U87-MG cells, BK channel expression and function were markedly upregulated
by growth conditions that enriched the culture in GBM stem-like cells (U87-NS). Cytofluorimetric analysis further confirmed the
appearance of a cell subpopulation that co-expressed high levels of BK channels and CD133, as well as other stem cell markers. A similar
association was also found in cells derived from freshly resected GBM biopsies. Finally, transwell migration tests showed that U87-NS cells
migration was much more sensitive to BK channel block than U87-MG cells. Our data show that BK channels are highly expressed in GBM
stem-like cells, and participate to their high migratory activity.
J. Cell. Physiol. 9999: 1–11, 2016.  2016 Wiley Periodicals, Inc.
Gliomas are major tumors involving glial cells in the central
nervous system, accounting for 35–50% of intracranial tumors
in adults. Among them, grade IV glioblastoma (GBM) has the
highest incidence and shortest patient survival of all brain
tumors. Currently, patients undergoing standard intervention,
consisting of gross surgical resection followed by radiotherapy
and chemotherapy, present an overall median survival of about
20 months. Great efforts are therefore made to identify new
molecular biomarkers in gliomas that enable a personalized
therapy of this highly heterogeneous tumor (Holland, 2001;
Eckel-Passow et al., 2015; Wang et al., 2015). The poor
prognosis of GBM is mainly caused by the diffuse invasion of
GBM cells into the healthy brain parenchyma, that makes full
surgical resection essentially impossible and radiation therapy
ineffectual (Maher et al., 2001). Understanding the mechanism
ofGBM cell migration and invasion is thus a key step to improve
the therapy against this tumor.
Several properties of cancers, including GBM, are influenced
by the dysregulation of ion channel expression and function
(Sontheimer, 2008; Catacuzzeno et al., 2012, 2014; Sforna
et al., 2015). One of themost studied dysregulated ion channels
in GBM cells is the large-conductance, calcium-activated K (BK)
channel, gated by the concerted action of both voltage and
intracellular calcium (Turner and Sontheimer, 2014). BK
channels are structurally made by the association of four pore-
forming a subunits, coded by only one gene (the KCNMA1)
whose transcript can undergo different splicing processes (Kyle
and Braun, 2014). Notably, when compared to normal
astrocytes, GBM cells overexpress a particular splicing isoform
of the BK channel (the glioma BK, gBK; Liu et al., 2002).
Moreover, modulatory ß subunits (ß1–ß4) can associate with
the BK channela subunits and increase the channel’s functional
diversity in terms of activation and deactivation kinetics,
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voltage-dependence, inactivation, and calcium sensitivity
(Torres et al., 2014). Among them, the b4 is by far the most
abundantly expressed in the brain (Weiger et al., 2000), and the
only one detected in GBM cells (Bednarczyk et al., 2013). In
GBM cells BK channels, working in concert with Cl channels,
promote transmembrane ion and water fluxes, critical for cell
volume and membrane potential changes, ultimately leading to
cell proliferation, migration, or death (Cuddapah and
Sontheimer, 2011). More specifically, BK channels have been
found to be involved in GBM migration through restricted
extracellular spaces, as well as in two-dimensional migration
promoted by menthol (Weaver et al., 2006; Catacuzzeno et al.,
2015). In addition, ionizing radiation promoted [Ca2þ]i
increases and BK channels activation, ultimately leading to
GBM cell migration (Steinle et al., 2011). All these data point to
a key role of BK channels in the migration/invasion of GBM
cells.
Recent evidence suggests that in several cases GBM
originates from a pool of stem-like cells that share properties in
common with neuronal stem cells, being capable of extensive
proliferation, self-renewal, and multi-lineage differentiation
(Maugeri-Sacca et al., 2013). Many data show that the stemness
behavior of GBM cells closely associates with an increased
aggressiveness and with the resistance to current anticancer
therapies, such as chemo- and radiotherapy (Bao et al., 2006;
Maugeri-Sacca et al., 2011). Most notably, GBM stem-like cells
also possess a greater invasive potential than non-stem tumor
cells (Inoue et al., 2010; Wu et al., 2011; Chen et al., 2013), but
the mechanism leading to this increased invasiveness is still
unclear. Based on these data we set out to investigate whether
the BK channels are expressed in GBM stem-like cells and are
involved in their migratory process.
Materials and Methods
Cell culture
U87-MG GBM cell line was purchased from American Type
Culture Collection (Manassas, VA) and was grown in DMEM-F12
supplemented with 10% heat-inactivated fetal bovine serum
(Sigma–Aldrich St. Louis, MO), 100 IU/ml penicillin G, 100mg/ml
streptomycin, 1% L-glutamine, 1% nonessential amino acids, and
1mM sodium pyruvate at 37°C in a 5% CO2-humidified
atmosphere. The medium was changed twice a week, and the cells
were subcultured when confluent. U87 neurospheres (U87-NS)
were derived from U87-MG by growing them in serum-free
DMEM-F12 supplemented with 20 ng/ml bFGF, 20 ng/ml EGF
(PeproTech, Rocky Hill, NJ) B-27, and N2 supplements (Life
Technologies, Carlsbad, CA) for up to 3 weeks. Neurospheres
were cultured for at least 10 days and before each experiment the
enrichment in CD133þ cells was evaluated by flow cytometry.
GBM primary cultures (WHO grade IV) were obtained in a
previous work by our group from tumor specimens of patients
(Calogero et al., 2001). For electrophysiological experiments
shown in Figure 1, cells were seeded in Petri dishes at 30,000
cells/ml and used after 3 h. For electrophysiological experiments
shown in Figures 2 and 6, cells were seeded in Petri dishes at
50,000 cells/ml and used after 3 h.
Electrophysiology
The whole-cell dialyzed configuration was used for
electrophysiological recordings from GBM cells (Fioretti et al.,
2006; Sforna et al., 2016). Currents–voltages were amplified with a
HEKA EPC-10 amplifier (List Medical, Darmstadt, Germany), and
analyzed with the Patch-Master package (version 2 69, HEKA
ELEKTRONIK) and Microcal Origin 8.0 software. For on-line data
collection, macroscopic currents were filtered at 3 kHz and
sampled at 200ms/point. The external solution contained (in mM):
NaCl 140, KCl 5, CaCl2 2, MgCl2 2, MOPS 5, glucose 10, (pH 7.4).
Octanol (1mM) was added to the external bathing solution to
block gap-junctions (Eskandari et al., 2002; Catacuzzeno et al.,
2011). TRAM-34 (3mM) was added to block Ca2þ-activated
intermediate-conductance K channels, expressed in these cells.
The internal solution contained: KCl 155, EGTA-K 1, MOPS 5,
MgCl2 1 (pH 7.2). Access resistances ranging between 4–8MΩ
were actively compensated to ca. 50%. All chemicals used were of
analytical grade. Dimethyl sulfoxide (DMSO),
tetraethylammonium chloride (TEA), 1,3-Dihydro-1-[2-hydroxy-
5-(trifluoromethyl) phenyl]-5-(trifluoromethyl)-2H-benzimidazol-
2-one (NS1619), were purchased from Sigma–Aldrich. Paxilline
and iberiotoxin were purchased from Alomone Labs (Jerusalem,
Israel). 1-[(2-Chlorophenyl) diphenylmethyl]-1H-pyrazole
(TRAM-34) was from Tocris Bioscience (Avonmouth, UK).
TRAM-34, NS169, and paxilline were prepared in DMSO (at
concentrations of 10, 10, and 5mM, respectively). The maximal
DMSO concentration in the recording solutions was 0.1%. We
verified that application of 0.1% DMSO did not have significant
effects on the membrane currents of U87-MG cells (data not
shown). The pharmacological agents were dissolved daily in the
appropriate solution at the concentrations stated, and bath applied
with a gravity perfusion system. Experiments were carried out at
room temperature (18–22°C). Data are presented as mean SE.
Statistical differences between experimental groups were verified
by using the t-test, and considering a level of significance (P) of 0.05.
RNA extraction and real time PCR
Cellular and tissue mRNA was isolated using RNeasy Mini kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. To extract RNA, cultured cells were grown in a
60-mm dish to 60–80% confluency and lysed. mRNA
concentration was quantified using a DU 800 Spectrophotometer
(Beckman Coulter, Indianapolis, IN). One microgram of mRNA
was converted to cDNA using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystem, CA) according to the
manufacturer’s instructions. Gene expression was quantified by
real-time PCR using the 7900HT Fast Real-time PCR System and
Power SYBR Green PCR Master Mix (Applied Biosystem,
Warrington, UK) according to themanufacturer’s instructions and
analyzed. Each experiment was performed in triplicate and is
expressed as mean SD. Experiments were independently
repeated three times. Gene expression levels were quantified
from real-time PCR data by the comparative threshold cycle (CT)
method using 18S as an internal control gene. The housekeeping
gene 18S was used as internal reference. The following gene-
specific primers were used: human KCNMA1 (QuantiTect Primer
Assay, QT00024157, Qiagen); human KCNMB1 FW 50-
CTGTACCACACGGAGGACACT-30, RV 50-
GTAGAGGCGCTGGAATAGGAC-30; human KCNMB2 FW 50-
CACTGAAGGCAGGAGAGGAC-30, RV 50-
GAGACTCTTCGGTCCACACG-30; human KCNMB3 FW 50-
GAGAGGACCGAGCCGTGATG-30, RV 50-
CACCACCTAGCAGAGTCAGTGAAG-30; human KCNMB4
FW 50-GCGTTCTCATTGTGGTCC-30, RV 50-
TTCCAGTTGTGCCTGTTTC-30.
Western blot
Cells were lysed in RIPA buffer (50mM Tris–HCl pH 8.0, 150mM
NaCl, 1% Nonidet P-40, 1mM EDTA, 0.5% sodium deoxycholate,
0.1% SDS) with protease inhibitors, 1mM PMSF, 1mM DTT, and
0.5mM sodium orthovanadate (Sigma–Aldrich). Protein
concentration was determined by the Bradford assay and 40mg of
proteins per sample were resolved on an 8% SDS–PAGE gel and
blotted onto a PVDF membrane (Amersham HyBond-P GE
Healthcare, UK). After blocking at RT in 5% dry-milk in TBS
containing 0.1% Tween-20 for 1 h, membranes were incubated
overnight at 4°C with rabbit polyclonal anti-CD133 antibody
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(dilution 1:500, abcam 19898), and mouse monoclonal anti-b-actin
(dilution 1:2000) antibody was used for normalization. Membranes
were then incubated with anti-rabbit and anti-mouse horseradish
peroxidase conjugated secondary antibodies (dilution 1:10000, GE
Healthcare Bio-Sciences, Piscataway, NJ). Immunocomplexes
were detected by ECL Western Blotting detection system (GE
Healthcare Bio-Sciences). Densitometric analysis was performed
with Image Studio software (LI-COR Biosciences, Lincoln, NE).
Cytometric analysis and cell sorting
Biparametric analysis was performed by BK/AlexaFluor 488
indirect staining followed by CD133/PE direct staining. Briefly,
U87-MG cells and neurospheres derived thereof (U87-NS) were
collected, washed, and resuspended in PBS, 2% FCS (106 cells/
100ml). Samples were incubated for 30min at 4°C with 10ml of
anti-BK (APC-151, Alomone Labs), washed and resuspended again
in 100ml of PBS, 2% FBS. AlexaFluor 488-conjugated mouse anti-
rabbit antibody (final dilution 1:250, A11034, Life Technologies)
was then added and the samples were incubated for additional
30min at 4°C. After an additional wash cells were stained for
30min at 4°C using 10ml of an anti-CD133-PE antibody (CD133/2,
clone 293C, Miltenyi Biotech, Calderara di Reno, Italy). At the end
of incubation, cells were washed again, resuspended in PBS, 2%
FBS, and the samples were acquired on a FACs ARIA II instrument
using FACs DiVa software (v.6.1.1, both by Becton Dickinson,
Milan, Italy). At least 20,000 events were recorded and analyzed
using Flowing software (v2.5.1, Turku Centre for Biotechnology,
Finland).
For the sorting of BK-enriched U87-NS population, cells were
stained as previously reported then washed and resuspended in
PBS, 2% FBS. Both BK-rich and BK-basal subpopulations were
isolated using FACs ARIA II and FACs DiVa software, then they
were checked again for BK expression after the sorting procedure.
Transwell migration assay
Cells were harvested, disaggregated, and resuspended in DMEM-
F12 with 0.2% FBS and 5 104 cells were seeded in 24-well cell
culture inserts with 8mm pore size membrane (Boyden chambers,
BD Biosciences). DMEM-F12 supplemented with 10% FBS was
added to the lower chamber as chemo-attractant. BK channel
blockers, either paxilline or iberiotoxin, were added to DMEM-
F12 at a concentration of 2 or 100 nM, respectively, and applied in
both the upper and lower part of the chamber. Cells were
incubated at 37°C for 18 h. After this time, cells were fixed with
Fig. 1. Expression of BK channels in U87-MG GBM cells. (A) Current traces obtained in response to depolarizing steps from 40 to þ140mV
from a holding potential of 60mV from a GBM cell held under the ionic conditions described in the text, in control conditions and after bath
application of 3mM TEA. (B) Bar plot showing the mean residual current recorded after bath application of TEA (3mM), Pax (2mM) e
NS1619 (20mM). (C) mRNA expression levels (vs. the 18S transcript) of the KCNMA1 and the four KCNMB transcripts in U87-MG cell line.
(D) Time course of the BK current at þ120mV showing the effect of successive application of 100 nM IbTx and 2mM paxilline. Inset: Current
traces obtained in control, Ibtx and IbTxþPax for the same experiment shown in the main panel. (E) Plot showing the mean residual current
after IbTx and IbTxþPax, assessed in six experiments similar to that shown in panel D.
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100% methanol and non migrated cells were removed from the
inner side of the insert with a cotton swab. Migrated cells, which
had the ability to push themselves through the 8mm pores, were
gently rinsed with PBS, stained with 0.25% crystal violet
(Sigma–Aldrich) for 15min, rinsed again and allowed to dry. Five
random fields per insert were photographed with a light
microscope (Leica DM 4000B) at 10 magnification and ImageJ
software was used to count cells. In all experiments, data were
collected from three chambers.
Immunohistochemistry
Paraffin-embedded tissues were deparaffinized, rehydrated in
descending graded alcohols, incubated for 15min in methanol
containing 3% H2O2 to block endogenous peroxidase activity, and
then subjected tomicrowave antigen retrieval for 20min in sodium
citrate buffer (10mM tri-sodium citrate dihydrate, 0.05% Tween
20, pH 6.0). After preincubation in normal horse serum for 1 h,
sections were incubated overnight with rabbit polyclonal anti-
CD133 antibody (dilution 1:200, abcam 19898) or rabbit
polyclonal anti-BK antibody (dilution 1:200, APC-151, Alomone
Labs) at 4°C in humid chamber, washed with PBS, incubated for 1 h
at room temperature with biotinylated universal secondary
antibody (Vectastain Universal Elite ABC kit, Vector Laboratories,
Burlingame, CA), washed with PBS and then incubated with the
avidin-biotin-peroxidase complex according to themanufacturer’s
instructions. The sections were then stained with 3-3-
diaminobenzidine (ImmPACT DAB peroxidase substrate, Vector
Laboratories) as chromogen to visualize the reaction product, and
were finally counterstained with hematoxylin.
Differentiation assay
U87 neurospheres at day 14 were trypsinized and disaggregated in
order to have a single cell suspension. 4 104 cells were plated in
60mm tissue culture petri dishes in DMEM supplemented with
10% FBS in presence or absence of 10mM paxilline and allowed to
differentiate for 5 days. Total RNAwas extracted and RT-PCRwas
performed to evaluate mRNA expression of the differentiation
marker GFAP and the stemness markers oct-4, sox-2, and nanog.
For immunofluorescence, 5 103 cells were plated on chamber
slides (Nunc Lab-Tek), fixed with 4% paraformaldehyde,
Fig. 2. Up-regulation of BK channels in U87-NS cells. (A and B) Western blot analysis showing the overexpression of CD133 protein in U87-
NS compared to U87-MG. (C) Enhanced expression of the mRNA for the BK channel a subunit, assessed by RT-PCR, in U87-NS as compared
to U87-MG. P< 0.05. (D) Current traces obtained in response to depolarizing steps from 40 to þ140mV from a holding potential of 60mV
from a U87-MG cell (left) and a BK-rich U87-NS cell (right). (E) Mean BK I–V assessed from U87-MG (n¼ 10) and U87-NS (n¼ 11) cells. (F)
Dot plot showing the cell-to-cell variability of the BK current density at þ100mV, recorded in U87-MG and U87-NS cells.
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permeabilized with 0.5% PBS-triton X-100, blocked 1 h with 0.2%
PBS-gelatin and stained overnight at 4°C with the following
primary antibodies: rabbit polyclonal anti-GFAP (dilution 1:300,
Sigma–Aldrich), mouse monoclonal anti-nestin (dilution 1:300,
Santa-Cruz, Dallas, TX) and mouse monoclonal anti-b-III tubulin
(dilution 1:300, Sigma–Aldrich). Secondary antibodies used were:
goat anti-mouse Alexa-fluor 594 conjugate and goat anti-rabbit
Alexa-fluor 488 (dilution 1:1000, Life Technologies). Nuclei were
counterstained with DAPI for 5min in the dark and mowiol was
used tomount coverslips on chamber slides. Images were acquired
with Nikon Eclipse Ni motorized microscope system at 10
magnification.
Statistical analysis
All statistical analyses were performed using the Origin v.8
software. A P-value< 0.05 was considered statistically significant.
Results
Expression of BK channel a and b subunits in U87-MG
GBM cells
We recorded BK currents from U87-MG GBM cells using the
whole-cell configuration of the patch-clamp method, and ionic
conditions suitable to isolate this current from others known
to be expressed in these cells (cf. Methods). Application of
depolarizing steps under these conditions elicited a time-
dependent outward current associated with a high noise,
typical of currents passing through the high-conductance BK
channels (Fig. 1A). This current was mostly blocked by
relatively low concentrations of TEA (3mM) and paxilline
(2mM), and enhanced by the BK channel activator NS1619
(20mM) (Fig. 1A and B). These pharmacological properties
indicate that under our conditions we are recording essentially
isolated BK currents. In accordance with the
electrophysiological data, RT-PCR analysis detected abundant
expression of the KCNMA1 transcript coding for the BK
channel a subunit (Fig. 1C), and, among the BK channel ß
subunits, only the ß4 isoform was significantly present in U87-
MG cells (Fig. 1C).
It is known that the association of the ß4 subunit to the BK a
subunit, besides other effects, gives rise to BK currents with
highly reduced sensitivity to the toxin blockers charybdotoxin
and iberiotoxin (IbTx), while maintaining the original sensitivity
to paxilline (Meera et al., 2000; Brenner et al., 2005). We
therefore, tested the sensitivity of the BK current expressed in
U87-MG cells to 100 nM IbTx and 2mM paxilline in order to
assess the degree to which the a subunit alone and the a/ß4
subunit complexes contribute to the overall macroscopic BK
current. As shown in Figure 1D and E, most of the paxilline-
sensitive current was also IbTx sensitive, suggesting that in
U87-MG cells most functional plasma membrane BK channels
do not contain ß4 subunits. These data suggest that ß4 subunits
may contribute to form BK channels in membrane
compartments other than the plamamembrane, such as
mitochondria (Bednarczyk et al., 2013).
Expression of BK channels inU87-NS versusU87-MGcells
Cell cultures enriched in stemness markers were obtained by
culturing U87-MG cells in stem cell permissive medium
(Ruggieri et al., 2012). Effective cell conditioning was assessed
by verifying with optical microscopy and cytofluorimetry, for
up to 3 weeks, the appearance of neurospheres and increased
fraction of CD133þ cells (FACS analysis indicated a mean
percentage of CD133þ cells of 49 4% in U87-NS cells). After
10 days of conditioning, U87-MG-derived neurospheres (U87-
NS) showed an evident increase in CD133 protein expression
(Fig. 2A and B). Consistent with the increased expression of
CD133, in U87-NS cell culture we found a marked inhibition of
the differentiation marker GFAP, and a marked upregulation of
the cancer stem cell markers, sox-2, nanog, and oct-4, as
compared to U87-MG cells, confirming the acquisition of stem-
like properties by these cells (data not shown; Ruggieri et al.,
2012).
We next assessed whether U87-NS cells displayed increased
BK currents as compared to U87-MG cells. As shown in
Figure 2E and F the mean BK current density in U87-NS cells was
about threefold higher than in U87-MG cells, suggesting a
differential expression of the BK channel in the two cell types. In
accordance, the expression of the KCNMA1 transcripts in U87-
NS cells was almost twofold higher than in control cells not
subject to stem cell permissivemedium (Fig. 2C). As shown in the
dot plot of Figure 2F, the BK current density of U87-NS cells
displayed a variability much higher than that observed in U87-MG
cells.More specifically, inU87-NSabout two thirdsof the cells had
a BK current density comparable to that observed in U87-MG
cells (BK-basal), while the others had BK current densities
markedly higher thanU87-MGcells, andwere called BK-rich cells.
Representative current traces fromaU87-MGcell and fromaBK-
richU87-NS cell, activated by depolarizing pulses as indicated, are
shown in Figure 2D.
U87-NS stem-like cells express increased
plasmamembrane BK channel levels
As in U87-NS cells mean BK currents and mRNA levels were
higher than in U87-MG cells, we hypothesized that high BK
channel expression associates with stem-like properties. To
verify this assumption, we assessed by cytometric analysis the
expression of both BK channels and the stemness marker
CD133 (Fig. 3). U87-MG cells showed a homogeneous
morphology and a weak, uniform positivity for the
plasmamembrane BK channel (Fig. 3A-a3), whereas they did
not express CD133 (Fig. 3A-a4). Cell conditioning to
neurospheres induced a clear change in cell morphology with
the appearance of two distinct subpopulations (cf. Fig. 3A-a1
with B-b1): the first (black population in Fig. 3B-b1)
characterized by a lower FSC and a higher SSC (e.g., smaller
size and higher internal complexity), and the second (light
gray population in Fig. 3B-b1) characterized by a higher FSC
and a lower SSC. In the first U87-NS subpopulation, about
21% of cells had high/very high expression of
plasmamembrane BK channel (BK-rich, Fig. 3B-b3) congruent
with data shown in Figure 2F, whereas 70% of cells were
CD133þ (Fig. 3B-b4). Furthermore, 25% of the cells in this
subpopulation co-expressed both markers (dot plot in
Fig. 3B-b2), which would imply that virtually all BK-rich cells
are positive to CD133. Conversely, the second
subpopulation was essentially negative for both markers
(Fig. 3B-b5-7). These results show the presence, in U87-NS
cells, of a BK-rich subpopulation highly expressing the CD133
marker.
The BK-rich subpopulation expresses high levels of other
stemness markers
We have shown that virtually all BK-rich U87-NS cells (ca 20%)
co-express CD133, making the BK channel a potential
stemness marker. To verify this proposition, in both the BK-
rich and BK-basal subpopulations we assessed the expression
of other stemness markers. To this purpose, we isolated BK-
rich and BK-basal subpopulations by cell sorting (Fig. 4, upper
panels), and on each subpopulation we assessed the expression
of several stemness markers by RT-PCR. As shown in Figure 4,
lower panel, BK-rich cells also expressed markedly higher
mRNA levels for oct-4, sox-2, and nanog, as compared to
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BK-basal cells. The strong segregation of BK channels with
several stemness markers makes these channels potential
candidates as marker for GBM stem cells.
Correlation between stem cell markers and BK channel
expression in primary cell lines
To verify whether the significant co-expression found
between stem cell markers and BK channels also occurred in
primary GBM cell lines, we estimated the mRNA levels of the
stemness marker CD133 and the BK channel a subunit in five
primary cell lines obtained from freshly resected biopsies. As
shown in Figure 5A, a highly significant correlation was found
between KCNMA1 and CD133 mRNA levels, with a Pearson
coefficient of 0.98 (P< 0.002). For one of the tested low-
passage primary cultures (FCN), we were able to record the
BK currents using the patch-clamp method. As found in
established GBM cell lines, FCN cells expressed mostly IbTx-
sensitive BK currents in response to depolarizing steps
(Fig. 5B). In contrast to both the U87-MG and the U87-NS
cell lines, the BK current expressed in these primary cells
showed an evident inactivation and a more hyperpolarized
steady-state activation threshold, suggesting the contribution
of ß subunits in determining these channel properties. In
accordance, using RT-PCR we found that this GBM primary
culture, in contrast to both the U87-NS and U87-MG cells,
expressed abundant levels of the ß2 subunit (Fig. 5D). From
this cell line we were able, upon cell conditioning with stem
cell permissive medium, to obtain neurospheres (FCN-NS)
from which we recorded BK currents. Notably, also FCN-NS
cells possessed a BK current sensibly higher than that
recorded in FCN cells (Fig. 5C and E). Finally, in a freshly
resected biopsy, from patient STC1, we used
immunohistochemistry to look at the BK and CD133 protein
expression (Fig. 5F). As shown, the BK channel is present in
all tumor areas examined, including perivascular sites, with a
percentage of clearly BK positive cells varying approximately
between 10% and 30%. The majority of neoplastic
multinucleated cells were instead negative or weakly positive
for BK. The expression of CD133 is similar in tissue
distribution but differs in the percentage of positive cells,
which varies between 30% and 40%. We also extracted from
the same tissue the total RNA and found higher KCNMA1
and CD133, and lower GFAP mRNA expression as compared
to that observed in biopsies from normal (non-tumoral)
tissue (Fig. 5G).
Fig. 3. Expression of CD133 in the BK-rich subpopulation of U87-NS cells. Cytometric analysis of U87-MG (A) and U87-NS (B) cells. FSC/SSC
cytograms show a uniform cell population for U87-MG (a1) and the appearance of two cellular subsets for U87-NS (b1). BK/CD133 co-
expression is shown for U87-MG (a2) and for the two cellular subsets of U87-NS (b2 and b5, respectively). Histogram plots show BK and CD133
expression in U87-MG (a3 and a4) and in the two cellular subsets of U87-NS (b3, b4, b6, and b7). One out of three independent experiments is
shown.
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Role of the BK channel in the migration of U87-MG and
U87-NS cells
Given the large plasmamembrane expression of BK channels in
U87-NS cells and their recognized role in cell volume
regulation, we looked for the contribution of these channels to
the migration of these cells. To this end, we performed
transwell migration assays and looked at the effects of BK
channel specific inhibition. As shown in Figure 6, paxilline (Pax)
had a small effect on U87-MG cell migration, but a strong
inhibitory effect (about 60% inhibition) on the migration of
U87-NS cells, suggesting that the overexpression of BK
channels in U87-NS cells is functionally relevant to promote
their migration. Since paxilline is membrane permeant, its effect
on cell migration may be also ascribed to block of
mithocondrial BK channels, much expressed in U87-MG cells
(Siemen et al., 1999; Bednarczyk et al., 2013). In order to
exclude this possibility, we tested the effects of the membrane-
impermeant IbTx on GBM cell migration. As shown in Figure 6,
IbTx displayed effects in line with those observed using
paxilline, suggesting that plasmamembrane BK channels are
those relevant for the migration of U87-NS cells.
Role of the BK channel in the differentiation of
U87-NS cells
Finally, we performed differentiation assays by using 10% FBS
as inductor of differentiation, and looked at neuronal (b-III
tubulin), astrocyte (GFAP), and stemness (nestin, oct-4,
nanog, and sox-2) markers by RT-PCR and
immunofluorescence. In addition, we repeated the
differentiation assays in presence of the BK channel blocker
paxilline to check the role of BK channel activity in the
differentiation of U87-NS cells. As shown by the
immunofluorescence in Figure 7, U87-NS cells expressed low
levels of both GFAP and b-III tubulin (Fig. 7B), and high levels
of nestin (Fig. 7C). In addition, oct-4, nanog, and sox-2
trancripts were upregulated (Fig. 7A), confirming the
Fig. 4. Expression of stemness markers other that CD133 in the BK-rich U87-NS cells. (A) FACS cell sorting of BK-rich and BK-basal cells
from U87-NS. (B) RT-PCR analysis showing mRNA expression of the stemness markers oct-4, sox-2, and nanog in BK-rich and BK-basal
cells.
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stemness properties of these cells. Treatment with 10% FBS
substantially increased both differentiation markers, and
decreased stemness markers, confirming the differentiation
ability of this maneuver. Notably, in presence of paxilline the
FBS-induced upregulation of GFAP was markedly strengthened,
while the induction of b-III tubulin appeared to be partially
prevented. In addition, paxilline enhanced the FBS-induced
downregulation of oct-4 and nanog (Fig. 7A). These results
suggest that the presence and activity of BK channels enhance
the stemness properties of U87-NS cells and preclude their
differentiation toward the astrocyte lineage, while favoring the
differentiation toward the neuronal lineage.
Fig. 5. Correlation between CD133 and BK channel expression in GBM primary cell lines. (A) Correlation plot between CD133 and
KCNMA1 mRNA levels from five primary cells lines obtained from freshly resected GBM biopsies. (B) Current traces in response to a
depolarizing pulse to þ100mV, in control and in presence of 100 nM IbTx, for a FCN primary GBM cell. (C) Current traces obtained in
response to depolarizing steps from 40 to þ140mV from a holding potential of 60mV from a FCN cell (left) and a FCN-NS cell (right).
(E) Mean BK I–V assessed from FCN (n¼ 9) and FCN-NS (n¼ 9) cells. (D) ß2 subunit transcript level in the same five primary cells lines,
assessed by RT-PCR. (F) Serial paraffin sections of fresh bioptic GBM tissue from STC1 patient were tested for BK and CD133 by
immunohistochemistry. Scale bar: 20mm. (G) Fresh tissue from the same STC1 tumor was processed for mRNA extraction and analyzed
by RT-PCR for KCNMA1, CD133, and GFAP genes. Normal (non-tumoral) brain tissue from same patient was used as control (ctrl).
P< 0.001.
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Discussion
The main findings reported in this work are that: (i) U87-MG
cells grown under conditions that enriched the culture in GBM
stem-like cells (U87-NS) express higher levels of BK channels
as compared to normally grown cells; (ii) the BK channel’s
increased expression in U87-NS cultures is due to the
enrichment of a BK-rich subpopulation expressing stem cell
markers; (iii) unlike U87-MG, U87-NS cell migration is strongly
sustained by the activity of BK channels. All these data indicate
that BK channels are highly expressed in GBM stem-like cells,
where they participate to their high migratory ability.
We found that U87-MG cells express a relatively high
density of BK currents that, at the low [Ca2þ]i used in our
recording solutions, activate at membrane depolarizations
higher than þ60mV. In this respect, the BK current of U87-
MG cells resembles those found in other GBM cell lines and
in GBM primary cultures isolated from freshly resected
biopsies (Ransom et al., 2002; Weaver et al., 2006; Fioretti
et al., 2009; Wondergem and Bartley, 2009; Abdullaev et al.,
2010; McFerrin et al., 2012). At the transcript level, we
found that U87-MG cells express both the mRNA coding for
the a and the ß4 subunits. However, the high sensitivity of
BK channels to relatively low concentrations of IbTx
suggests that the ß4 subunit, while if expressed at protein
level, does not participate to form plasmamembrane
functional BK channels. Notably, in some neuronal cell types
it has been found that ß4 subunits do not significantly reach
the plasmamembrane, but are retained in the endoplasmic
reticulum where they modulate negatively the
plasmamembrane targeting of the BK a subunits (Shruti
et al., 2012). Alternatively, ß4 subunits may participate to
form functional BK channels in subcellular compartments
other than the plasmamembrane. Interestingly, recent
works suggest a significant expression of ß4 subunits at the
mitochondrial membrane of GBM cells, where ion channels
with typical BK channels properties have been often
identified (Siemen et al., 1999; Bednarczyk et al., 2013; Gu
et al., 2014).
A main finding of this study is that GBM stem-like cells
express BK channels at a much higher density than
non-stem-like cells. More specifically, we found that U87-MG
cells conditioned with growth factors that enrich the culture
in cells expressing stem cell markers (U87-NS cells) express a
mean BK current density significantly higher than U87-MG
cells grown in serum-containing medium. Consistent with
these data, the mRNA levels for the BK a subunit in U87-NS
cells were markedly higher as compared to U87-MG cells.
FACS analysis showed that U87-NS cells expressing high
levels of plasmamembrane BK channels also expressed
relatively high levels of the stem cell marker CD133.
Interestingly, a strong correlation between the level of the
BK channel a subunit transcripts and the CD133 transcripts
was also found in primary GBM cultures derived from freshly
resected biopsies. This result suggests that the
overexpression of BK channels in CD133-positive, stem-like
GBM cells is not a specific feature of U87 cells, but a general
feature of GBM. Several studies have reported a high BK
channel expression in cells with stem-like properties. A
relatively high density of BK channels was found in mouse and
human embryonic stem cells (Soria et al., 2013), and in
mesenchymal stem cells derived from both human-induced
pluripotent stem cells and bone marrow (Zhang et al., 2012).
The expression level of BK channels in oligodendroglial
precursor cells was found to decrease with developmental
age (Buttigieg et al., 2011). Finally, as found in several GBM
cell types, BK channels were found significantly more
expressed in the CD133-positive subpopulation of
neuroblastoma SH-SY5Y cells as compared to the CD133-
negative subpopulation (Park et al., 2010). All these evidences
suggest that the high expression of BK channels is a general
feature of cells with stem-like properties. We are aware that
GBM cancer stem cells represent a heterogeneous
population, and that CD133 may not be expressed in some
subgroups of stem-like cells (Beier and Beier, 2011).
Nevertheless, we selected CD133 as stemness marker given
the wide literature demonstrating its role in tumorigenesis
and in the maintenance of the stemness properties (Choy
et al., 2012; Brescia et al., 2013).
A number of works have shown that GBM stem-like cells
have a strong invasive potential, and this property
contributes to the increased aggressiveness of this cell
subpopulation as compared to non-stem like cells (Yu and
Bian, 2009; Inoue et al., 2010; Wu et al., 2011; Chen et al.,
2013). BK channel activity has been shown essential for
GBM cell migration, especially when cells infiltrate through
the narrow extracellular space typical of the healthy brain
parenchyma, that likely requires significant volume changes
(Soroceanu et al., 1999; Weaver et al., 2006). Based on
these evidences, we hypothesized that the increased
expression of BK channels in GBM stem-like cells may be
instrumental to their increased migratory ability. In
accordance, we found that the BK channel inhibitor paxilline
was highly effective in contrasting migration of U87-NS as
compared to U87-MG cells. The effect of BK channel
silencing on the migration of U87-MG was also
demonstrated by Edalat et al. (2016). Our results are in
accordance with a prominent role of BK channels in
establishing the migratory activity of stem-like GBM cells,
and suggest that the inhibition of these channels may
represent a potential strategy to reduce the aggressiveness
of this important GBM cell subpopulation.
We finally found that BK channels may have a significant role
in maintaining the stemness properties of GBM stem-like cells.
Using a differentiation assay based on the induction of
differentiation by FBS, we indeed found that block of BK
channel by paxilline substantially interfered with the
differentiation of U87-NS cells, in a way to suggest that the
activity of BK channels in U87-NS cells precludes the
differentiation toward the astrocyte lineage, while favoring the
Fig. 6. Effects of BK channel inhibition on the transwell migration
of U87-MG and U87-NS cells. Plot showing the percentage of
migrated U87-MG (white) and U87-NS (black) cells, tested under
control condition, in presence of 2mM Pax, or in presence of 100nM
IbTx. A markedly different inhibition by Pax and IbTx was observed
in the two different cell types (P< 0.001).
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Fig. 7. Effects of BK channel inhibition on differentiation of U87-NS. (A) RT-PCR analysis showing mRNA expression of GFAP and the
stemness markers oct-4, SOX-2, and nanog in differentiated U87-NS (cultured for 5 days with 10% FBS) in presence or absence of 10mM Pax
compared to undifferentiated U87-NS cells (P< 0.01; P< 0.001). (B and C) Co-expression of GFAP (green)/b-III tubulin (red) (B) and
GFAP (green)/nestin (red) (C) in U87-NS cells differentiated for 5 days with 10% FBS in presence or absence of Pax. Magnification 10.
JOURNAL OF CELLULAR PHYSIOLOGY
10 R O S A E T A L.
differentiation toward the neuronal lineage. Block of BK
channels also resulted in a stronger differentiation ability of
U87-NS cells. These results suggest that modulation of this
channel may be considered in GBM therapies based on tumor
cell differentiation.
In conclusion, we have shown that plasmamembrane BK
channels are highly expressed in GBM stem-like cells, where
they participate to their high migratory ability. These data point
to BK channels as a potential therapeutic target for this
pathology allowing to identify new molecular characteristics of
the GBM regulation network that may increase the precision of
personalized medication.
Acknowledgments
The authors would like to acknowledge the financial support of
MIUR-PRIN (20108WT59Y.004), Ministero della Salute (GR-
2009-1580433), and Fondazione Cassa di Risparmio di Perugia
(2012.0240.021 and 2014/2221).
Literature Cited
Abdullaev IF, Rudkouskaya A, Mongin AA, Kuo YH. 2010. Calcium-activated potassium
channels BK and IK1 are functionally expressed in human gliomas but do not regulate cell
proliferation. PLoS ONE 5:e12304.
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich
JN. 2006. Glioma stem cells promote radioresistance by preferential activation of the
DNA damage response. Nature 444:756–760.
Bednarczyk P, Wieckowski MR, Broszkiewicz M, Skowronek K, Siemen D, Szewczyk A.
2013. Putative structural and functional coupling of the mitochondrial BK(Ca) channel to
the respiratory chain. PLoS ONE 8:e68125.
Beier CP, Beier D. 2011. CD133 negative cancer stem cells in glioblastoma. Front Biosci
(Elite Ed) 3:701–710.
Brenner R, Chen QH, Vilaythong A, Toney GM, Noebels JL, Aldrich RW. 2005. BK channel
beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe
seizures. Nat Neurosci 8:1752–1759.
Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, Pelicci G. 2013. CD133 is essential for
glioblastoma stem cell maintenance. Stem Cells 31:857–869.
Buttigieg J, Eftekharpour E, Karimi-Abdolrezaee S, Fehlings MG. 2011. Molecular and
electrophysiological evidence for the expression of BK channels in oligodendroglial
precursor cells. Eur J Neurosci 34:538–547.
Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, Lombari V, Zani M,
Giannini G, Gagliardi FM, Caruso R, Gulino A, Frati L, Ragona G. 2001. The early growth
response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of
ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res 7:2788–2796.
Catacuzzeno L, Aiello F, Fioretti B, Sforna L, Castigli E, Ruggieri P, Tata AM, Calogero A,
Franciolini F. 2011. Serum-activated K and Cl currents underlay U87-MG glioblastoma cell
migration. J Cell Physiol 226:1926–1933.
Catacuzzeno L, Michelucci A, Sforna L, Aiello F, Sciaccaluga M, Fioretti B, Castigli E,
Franciolini F. 2014. Identification of key signaling molecules involved in the activation of
the swelling-activated chloride current in human glioblastoma cells. J Membr Biol
247:45–55.
Catacuzzeno L, Caramia M, Sforna L, Belia S, Guglielmi L, D’AdamoMC, Pessia M, Franciolini
F. 2015. Reconciling the discrepancies on the involvement of large-conductance Ca(2þ)-
activatedK channels in glioblastoma cell migration. Front Cell Neurosci 9:152.
Catacuzzeno L, Fioretti B, Franciolini F. 2012. Expression and role of the intermediate-
conductance calcium-activated potassium channel KCa3.1 in glioblastoma. J Signal
Transduct 2012:421564.
Chen X, Chen L, Chen J, HuW, Gao H, Xie B,Wang X, Yin Z, Li S, Wang X. 2013. ADAM17
promotes U87 glioblastoma stem cell migration and invasion. Brain Res 1538:151–158.
Choy W, Nagasawa DT, Trang A, Thill K, Spasic M, Yang I. 2012. CD133 as a marker for
regulation and potential for targeted therapies in glioblastoma multiforme. Neurosurg
Clin N Am 23:391–405.
Cuddapah VA, Sontheimer H. 2011. Ion channels and transporters [corrected] in cancer. 2.
Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol
301:541–549.
Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci
M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada
AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR,
O’Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM,
Prados MD,Wiemels J,Wiencke JK,WrenschMR, Jenkins RB. 2015. Glioma groups based
on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499–2508.
Edalat L, Stegen B, Klumpp L, Haehl E, Schilbach K, Lukowski R, K€uhnle M, Bernhardt G,
Buschauer A, Zips D, Ruth P, Huber SM. 2016. BK Kþ channel blockade inhibits radiation-
induced migration/brain infiltration of glioblastoma cells. Oncotarget 7:14259–14278.
Eskandari S, Zampighi GA, Leung DW,Wright EM, Loo DD. 2002. Inhibition of gap junction
hemichannels by chloride channel blockers. J Membr Biol 185:93–102.
Fioretti B, Castigli E, Micheli MR, Bova R, SciaccalugaM, Harper A, Franciolini F, Catacuzzeno
L. 2006. Expression and modulation of the intermediate- conductance Ca2þ-activated
Kþ channel in glioblastoma GL-15 cells. Cell Physiol Biochem 18:47–56.
Fioretti B, Catacuzzeno L, Sforna L, Aiello F, Pagani F, Ragozzino D, Castigli E, Franciolini F.
2009. Histamine hyperpolarizes human glioblastoma cells by activating the intermediate-
conductance Ca2þ-activated Kþ channel. Am J Physiol Cell Physiol 297:C102–C110.
Gu XQ, Pamenter ME, Siemen D, Sun X, Haddad GG. 2014. Mitochondrial but not
plasmalemmal BK channels are hypoxia-sensitive in human glioma. Glia 62:504–513.
Holland EC. 2001. Gliomagenesis: Genetic alterations and mouse models. Nat Rev Genet
2:120–129.
Inoue A, Takahashi H, Harada H, Kohno S, Ohue S, Kobayashi K, Yano H, Tanaka J, Ohnishi
T. 2010. Cancer stem-like cells of glioblastoma characteristically express MMP-13 and
display highly invasive activity. Int J Oncol 37:1121–1131.
Kyle BD, Braun AP. 2014. The regulation of BK channel activity by pre- and post-translational
modifications. Front Physiol 5:316.
Liu X, Chang Y, Reinhart PH, Sontheimer H, Chang Y. 2002. Cloning and characterization of
glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci
22:1840–1849.
Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA.
2001. Malignant glioma: Genetics and biology of a gravematter. Genes Dev 15:1311–1333.
Maugeri-Sacca M, Di Martino S, De Maria R. 2013. Biological and clinical implications of
cancer stem cells in primary brain tumors. Front Oncol 3:6.
Maugeri-Sacca M, Zeuner A, De Maria R. 2011. Therapeutic targeting of cancer stem cells.
Front Oncol 1:10.
McFerrin MB, Turner KL, Cuddapah VA, Sontheimer H. 2012. Differential role of IK and BK
potassium channels as mediators of intrinsic and extrinsic apoptotic cell death. Am J
Physiol Cell Physiol 303:C1070–C1078.
Meera P, Wallner M, Toro L. 2000. A neuronal beta subunit (KCNMB4) makes the large
conductance, voltage- and Ca2þ-activated Kþ channel resistant to charybdotoxin and
iberiotoxin. Proc Natl Acad Sci USA 97:5562–5567.
Park JH, Park SJ, Chung MK, Jung KH, Choi MR, Kim Y, Chai YG, Kim SJ, Park KS. 2010. High
expression of large-conductance Ca2þ-activated Kþ channel in the CD133þ
subpopulation of SH-SY5Y neuroblastoma cells. Biochem Biophys Res Commun
396:637–642.
Ransom CB, Liu X, Sontheimer H. 2002. BK channels in human glioma cells have enhanced
calcium sensitivity. Glia 38:281–291.
Ruggieri P, Mangino G, Fioretti B, Catacuzzeno L, Puca R, Ponti D, Miscusi M,
Franciolini F, Ragona G, Calogero A. 2012. The inhibition of KCa3.1 channels
activity reduces cell motility in glioblastoma derived cancer stem cells. PLoS ONE 7:
e47825.
Sforna L, Cenciarini M, Belia S, D’Adamo MC, Pessia M, Franciolini F, Catacuzzeno L. 2015.
The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma. Front Cell
Neurosci 15:467.
Sforna L, Cenciarini M, Belia S, Michelucci A, Pessia M, Franciolini F, Catacuzzeno L. 2016.
Hypoxia modulates the swelling-activated Cl current in human glioblastoma cells: Role in
volume regulation and cell survival. J Cell Physiol In press.
Shruti S, Urban-Ciecko J, Fitzpatrick JA, Brenner R, Bruchez MP. 2012. The brain-specific
Beta4 subunit downregulates BK channel cell surface expression. PLoS ONE 7:e33429.
SiemenD, Loupatatzis C, Borecky J, Gulbins E, Lang F. 1999. Ca2þ-activatedK channel of the
BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem
Biophys Res Commun 257:549–554.
SontheimerH. 2008. An unexpected role for ion channels in brain tumormetastasis. Exp Biol
Med (Maywood) 233:779–791.
Soria B, Navas S, Hmadcha A, Hamill OP. 2013. Single mechanosensitive and Ca2þ-sensitive
channel currents recorded from mouse and human embryonic stem cells. J Membr Biol
246:215–230.
Soroceanu L, Manning TJ, Jr, Sontheimer H. 1999. Modulation of glioma cell migration and
invasion using Cl() and K(þ) ion channel blockers. J Neurosci 19:5942–5954.
Steinle M, Palme D, Misovic M, Rudner J, Dittmann K, Lukowski R, Ruth P, Huber SM. 2011.
Ionizing radiation induces migration of glioblastoma cells by activating BK K(þ) channels.
Radiother Oncol 101:122–126.
Torres YP, Granados ST, Latorre R. 2014. Pharmacological consequences of the
coexpression of BK channel a and auxiliary b subunits. Front Physiol 5:383.
Turner KL, Sontheimer H. 2014. Cl- and Kþ channels and their role in primary brain tumour
biology. Philos Trans R Soc Lond B Biol Sci 369:20130095.
Wang J, Su HK, Zhao HF, Chen ZP, To SS. 2015. Progress in the application of molecular
biomarkers in gliomas. Biochem Biophys Res Commun 465:1–4.
Weaver AK, Bomben VC, Sontheimer H. 2006. Expression and function of calcium-activated
potassium channels in human glioma cells. Glia 54:223–233.
Weiger TM, Holmqvist MH, Levitan IB, Clark FT, Sprague S, Huang WJ, Ge P, Wang C,
Lawson D, Jurman ME, Glucksmann MA, Silos-Santiago I, DiStefano PS, Curtis R. 2000.
A novel nervous system beta subunit that downregulates human large conductance
calcium-dependent potassium channels. J Neurosci 20:3563–3570.
Wondergem R, Bartley JW. 2009. Menthol increases human glioblastoma intracellular
Ca2þ, BK channel activity and cell migration. J Biomed Sci 16:90.
Wu DG, Wang YY, Fan LG, Luo H, Han B, Sun LH, Wang XF, Zhang JX, Cao L, Wang XR,
You YP, Liu N. 2011. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal
adhesion kinase expression. Chin Med J (Engl) 124:2616–2621.
Yu SC, Bian XW. 2009. Enrichment of cancer stem cells based on heterogeneity of
invasiveness. Stem Cell Rev 5:66–71.
Zhang J, Chan YC, Ho JC, Siu CW, Lian Q, Tse HF. 2012. Regulation of cell proliferation of
human induced pluripotent stem cell-derived mesenchymal stem cells via ether-a-go-go 1
(hEAG1) potassium channel. Am J Physiol Cell Physiol 303:C115–C125.
JOURNAL OF CELLULAR PHYSIOLOGY
B K C H A N N E L S I N G L I O B L A S T O M A S T E M C E L L S 11
